Biogen Inc.
BIIB
$147.37
$3.602.50%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 6.81% | 670.48% | -1.35% | 1.42% | -54.63% |
| Total Depreciation and Amortization | 31.33% | 46.24% | 35.35% | 31.34% | 16.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.10% | -40.98% | 178.92% | 73.13% | 90.30% |
| Change in Net Operating Assets | 104.37% | -25.64% | -44.08% | -24.23% | 34.37% |
| Cash from Operations | 5,987.20% | 57.93% | 28.50% | 21.50% | 107.14% |
| Capital Expenditure | 39.72% | 52.83% | 52.82% | 31.08% | 24.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 83.04% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 508.82% | -101.53% | 173.26% | 97.73% | 106.22% |
| Cash from Investing | 97.15% | 32.21% | 161.91% | 93.07% | -362.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 102.56% | -158.41% | 148.98% | 8.76% | 152.70% |
| Cash from Financing | 101.22% | -100.78% | -2,402.04% | -912.90% | -8,631.08% |
| Foreign Exchange rate Adjustments | -255.32% | 247.74% | -207.32% | -215.50% | -28.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 154.59% | 36.44% | 397.61% | 104.70% | -383.03% |
